Pioglitazone Hydrochloride
Product Images NDC 71335-2082

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 71335-2082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Label (Lbl713352082)

Label (Lbl713352082)
Pioglitazone 30mg Tablet label by Bryant Ranch Prepack. The label compares to Actos 30mg Tablet by Celltrion Pharm Inc. The tablets are described as white to off-white round tablets. The label includes storage instructions, a barcode, and the NDC 71335-20821.*
FDA Label Image

Figure-1 (Pio Figure 1 Jpeg)

Figure-1 (Pio Figure 1 Jpeg)
A line graph depicting the mean response over 26 weeks for Pioglitazone Hydrochloride at doses of 15 mg, 30 mg, and 45 mg compared to placebo. The x-axis represents weeks (0 to 26), and the y-axis shows mean values ranging from -2.0 to 1.0. Four lines represent placebo (blue crosses), 15 mg (red squares), 30 mg (green triangles), and 45 mg (black diamonds) doses.*
FDA Label Image

Pioglitazone-structure (Pio Structure Jpeg)

Pioglitazone-structure (Pio Structure Jpeg)
Chemical structure of Pioglitazone Hydrochloride showing its molecular arrangement including aromatic rings, sulfur-containing ring, and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.